As of August 30, 2026, MDL 3004 remains paused for settlement administration rather than active bellwether trials. The most recent confirmed development is California’s paraquat ban, signed August 13, 2026 — the first major agricultural state to prohibit the herbicide, following Vermont’s ban earlier in 2026. Separately, court filings from August 4, 2026 show the MDL holding steady at 6,655 pending cases, unchanged from early July, while new claims are still being accepted. No global settlement has been finalized, though a Qualified Settlement Fund was approved in March 2026 to eventually process payouts. Judge Nancy Rosenstengel continues to press plaintiffs who opted out of the proposed settlement framework — in one instance, 183 of 217 clients from a single law firm rejected their offers — to meet with a court-appointed Special Master and sit for depositions.
Last updated: August 2026
The paraquat lawsuit is one of the largest active mass tort litigations in the United States right now. Thousands of farmers, farm workers, and rural residents have filed claims linking paraquat herbicide exposure to Parkinson’s disease diagnoses.
If you or someone in your family worked around paraquat and later developed Parkinson’s, you may be eligible for substantial financial compensation. Some individual claims have been valued in the hundreds of thousands of dollars.
This article covers everything you need to know for 2026: who qualifies, what settlements look like, where the litigation stands, and how to get your claim started before key deadlines close.
What Is the Paraquat Lawsuit in 2026?
The paraquat lawsuit is a legal action against the makers and distributors of paraquat dichloride, a highly toxic herbicide widely used in American agriculture for decades.
Plaintiffs in these cases argue that Syngenta AG and Chevron Phillips Chemical Company knew, or should have known, that paraquat caused Parkinson’s disease. They claim both companies hid that risk from consumers, farm workers, and regulators.
By 2026, well over 5,000 individual cases have been consolidated into multidistrict litigation in federal court. The case is being handled in the Southern District of Illinois under MDL 3004.
This is not a small consumer product dispute. It’s one of the most significant toxic tort cases in recent American legal history.
| Basic Case Facts | Details |
|---|---|
| Chemical at Issue | Paraquat dichloride (Gramoxone) |
| Primary Defendants | Syngenta AG, Chevron Phillips |
| Court | Southern District of Illinois |
| MDL Number | MDL 3004 |
| Presiding Judge | Judge Nancy Rosenstengel |
| Primary Injury Claimed | Parkinson’s disease |
Paraquat Lawsuit Status Update: Where Things Stand Right Now
As of 2026, the paraquat litigation is deep into what legal observers call the “bellwether trial phase.” This is when a small set of representative cases go to trial before a jury.
These early verdicts do not bind every claimant. What they do is signal to both sides what a full trial result might look like. That signal drives settlement negotiations.
Syngenta and Chevron have, so far, contested liability aggressively. No global settlement has been publicly announced as of early 2026. But litigation timelines and bellwether outcomes are pushing both sides toward resolution talks.
Current status as of 2026: Active litigation, bellwether phase, no confirmed global settlement.
The sheer volume of cases means this matter will not simply disappear. Courts, plaintiffs, and defendants alike have every incentive to move toward resolution.
| Litigation Phase | Status in 2026 |
|---|---|
| MDL Consolidation | Complete |
| Discovery | Largely complete |
| Bellwether Trials | Ongoing |
| Global Settlement | Not yet announced |
| New Filings Accepted | Yes |
Is This a Paraquat Class Action Lawsuit or a Mass Tort?
Many people searching for a “paraquat class action lawsuit” are actually looking at mass tort litigation, and the difference matters for your wallet.
In a true class action, all claimants share one settlement pot. Payouts are often small and uniform. Think data breach settlements where people get $25 gift cards.
The paraquat litigation is a mass tort. Every claimant files their own individual lawsuit. Cases are consolidated in one court for efficiency, but each plaintiff gets their own evaluation of damages, exposure history, and medical evidence.
That structure means payouts are not split equally. A claimant with 20 years of occupational exposure and advanced Parkinson’s will likely receive far more than someone with minimal contact and early-stage symptoms.
Key Takeaway: Mass tort means your payout is individual. Your specific exposure history and medical diagnosis directly control your settlement value.
The Paraquat Parkinson’s Disease Lawsuit Explained
The paraquat Parkinson’s disease lawsuit is built on a single core argument: paraquat is a known neurotoxin, and prolonged exposure causes the kind of brain cell destruction that leads to Parkinson’s disease.
Parkinson’s is a progressive neurological disorder. It destroys dopamine-producing neurons in the brain. Once those neurons are gone, they do not come back.
Plaintiffs argue that research linking paraquat to Parkinson’s was available to manufacturers for decades. Internal documents produced in discovery have reportedly shown that some company scientists were aware of the neurological risk long before warnings were updated.
The claims are personal injury claims, not property damage. They seek compensation for medical costs, lost wages, pain, suffering, and loss of quality of life.
| Claim Type | What Plaintiffs Seek |
|---|---|
| Medical Expenses | Past and future treatment costs |
| Lost Income | Wages lost due to disability |
| Pain and Suffering | Non-economic damages |
| Loss of Quality of Life | Lifestyle and independence impacts |
| Wrongful Death | Filed by family members of deceased victims |
How Is Paraquat Exposure Linked to Parkinson’s Disease?
The scientific link between paraquat and Parkinson’s disease is well established in peer-reviewed research. It is not a fringe theory.
The National Institute of Environmental Health Sciences has funded multiple studies showing that paraquat exposure significantly increases the risk of developing Parkinson’s. One major study found that people exposed to paraquat were 2.5 times more likely to develop Parkinson’s than those with no exposure.
Paraquat causes oxidative stress in brain cells. It specifically damages the dopaminergic neurons in the substantia nigra region of the brain. Those are the exact neurons that Parkinson’s disease destroys.
What makes this particularly damning in court is that paraquat’s molecular structure is chemically similar to a known Parkinson’s-causing neurotoxin called MPTP. Scientists have used paraquat to deliberately induce Parkinson’s symptoms in laboratory animal studies for years.
- NIEHS-funded research confirms elevated Parkinson’s risk
- Paraquat causes oxidative stress in dopamine-producing brain cells
- Chemical similarity to MPTP is documented in published science
- Animal studies have replicated Parkinson’s symptoms using paraquat exposure
Key Takeaway: The science connecting paraquat to Parkinson’s is not disputed by neutral researchers. It has been replicated in multiple independent studies over more than two decades.
What Symptoms Qualify for the Paraquat Lawsuit?
To qualify for the paraquat lawsuit, the primary medical condition at issue is a Parkinson’s disease diagnosis. That is the qualifying injury in virtually all active claims.
Parkinson’s disease symptoms that courts and legal teams look for include the following:
- Tremors, typically starting in hands or fingers at rest
- Stiffness or rigidity in limbs and trunk
- Slowness of movement (bradykinesia)
- Impaired balance and coordination
- Changes in speech pattern or softening of voice
- Reduced facial expressions (masked face)
- Cognitive changes or dementia in advanced stages
It is not enough to experience some of these symptoms. You need a formal Parkinson’s diagnosis from a licensed physician or neurologist. Medical records documenting the diagnosis are required to build a claim.
Some attorneys are also reviewing claims involving Parkinson’s-related disorders such as atypical Parkinsonism. These cases require stronger medical documentation but have been accepted in the MDL.
| Qualifying Condition | Documentation Needed |
|---|---|
| Parkinson’s disease | Neurologist diagnosis, medical records |
| Atypical Parkinsonism | Specialist evaluation, detailed records |
| Parkinson’s Plus syndromes | Case-by-case attorney review |
Syngenta’s Role in the Paraquat Lawsuit
Syngenta AG is the primary defendant in the paraquat lawsuit. The Swiss-based agrochemical giant is one of the largest pesticide manufacturers in the world.
Syngenta sells paraquat under the brand name Gramoxone in the United States. They acquired the paraquat business line through the purchase of Zeneca’s agrochemical division in the late 1990s. That acquisition came with decades of prior research and internal documentation on paraquat’s effects.
Plaintiffs’ attorneys have focused heavily on what Syngenta knew and when they knew it. Documents produced during discovery have reportedly shown internal awareness of neurological risk concerns that predates any public warning labels addressing Parkinson’s risk.
Syngenta has denied all liability. They maintain that paraquat, when used as directed, is safe and that the scientific evidence does not establish a causal connection. Their defense strategy has centered on challenging the reliability of plaintiffs’ expert witnesses.
Key Takeaway: Syngenta is the central defendant. The core legal battle involves what their internal documents show about what they knew about paraquat’s neurological risks.
Chevron’s Role in the Paraquat Litigation
Chevron Phillips Chemical Company is the second major defendant in the paraquat mass tort. Their involvement stems from a different part of the product’s history.
Chevron was involved in distributing and selling paraquat in the United States market for an extended period. Plaintiffs argue that Chevron’s distribution activity makes them jointly liable for injuries caused by the product.
Chevron has similarly contested liability throughout the litigation. Their defense team has mirrored many of Syngenta’s arguments, challenging causation evidence and the qualifications of plaintiffs’ expert witnesses.
It is worth understanding that in mass tort cases, multiple corporate defendants sharing liability is common. Settlements from each defendant may be separate or combined, depending on how the litigation resolves.
| Defendant | Role | Defense Strategy |
|---|---|---|
| Syngenta AG | Manufacturer, primary defendant | Challenges expert science, denies causation |
| Chevron Phillips | Distributor, secondary defendant | Challenges causation, shared liability arguments |
Who Qualifies for the Paraquat Lawsuit?
You may qualify for the paraquat lawsuit if you were exposed to paraquat and later developed Parkinson’s disease. That is the core two-part test.
The exposure must be meaningful. Courts and attorneys look for documented or demonstrable contact with paraquat through one of these exposure types:
- Occupational exposure: Licensed pesticide applicators, farm workers, agricultural employees who directly handled or sprayed paraquat
- Bystander exposure: People who lived or worked near fields that were regularly treated with paraquat
- Residential proximity: Individuals in rural areas with sustained exposure through airborne drift or water contamination
The Parkinson’s diagnosis must follow the exposure. Courts generally expect a diagnosis after a period of exposure, not before.
Age at time of diagnosis matters. Early-onset Parkinson’s (before age 60) in someone with farm or agricultural background is viewed as a strong indicator of potential eligibility.
| Exposure Category | Examples | Eligibility Strength |
|---|---|---|
| Direct applicator | Licensed sprayer, farm hand | Very strong |
| Farm worker proximity | Working in treated fields | Strong |
| Residential bystander | Living adjacent to treated land | Moderate, case-specific |
| Incidental contact | Single or rare exposure events | Weak, unlikely to qualify |
Key Takeaway: You need both paraquat exposure AND a Parkinson’s diagnosis. One without the other is not enough to file a viable claim.
Paraquat Lawsuit Eligibility: Breaking Down the Requirements
Eligibility for the paraquat lawsuit has specific requirements that go beyond just exposure and diagnosis.
Medical requirements:
- Formal diagnosis of Parkinson’s disease or a recognized Parkinson’s-related disorder
- Diagnosis must be from a licensed physician or neurologist
- Medical records documenting the diagnosis and timeline must be available
Exposure requirements:
- Exposure to paraquat must have occurred in the United States
- Exposure typically must predate the Parkinson’s diagnosis by a meaningful period
- The exposure must be documentable: employment records, geographic location, eyewitness accounts, purchase history, or proximity evidence
Time requirements:
- Each state has its own statute of limitations for personal injury claims
- Most states allow 2 to 3 years from the date you discovered the connection between your exposure and your diagnosis
- The “discovery rule” means the clock often starts when you learned paraquat may have caused your Parkinson’s, not when you were first exposed
Talk to a mass tort attorney as early as possible. State deadlines vary significantly.
Paraquat Lawsuit Deadline 2026: Do Not Miss This Window
Filing deadlines for the paraquat lawsuit vary by state, but 2026 is a critical year for many potential claimants. Missing a statute of limitations means permanently losing the right to file.
The “discovery rule” applies in most paraquat cases. The clock starts when a person knew or reasonably should have known that their Parkinson’s may be connected to paraquat exposure. Since paraquat’s Parkinson’s link has received heavy media attention since 2021 and 2022, courts may view the discovery clock as running for many claimants who have not yet filed.
Do not assume you have unlimited time. Waiting even a few months in 2026 could put your claim past the legal deadline in your state.
| State | Typical Personal Injury Statute of Limitations |
|---|---|
| California | 2 years from discovery |
| Illinois | 2 years from discovery |
| Texas | 2 years from discovery |
| Florida | 2 years from discovery |
| Iowa | 2 years from discovery |
| Kansas | 2 years from discovery |
| North Carolina | 3 years from discovery |
These are general figures. Exact deadlines depend on your specific facts. Confirm with a licensed attorney in your state.
Paraquat Settlement Amount: What Are Cases Worth?
Paraquat settlement amounts have not been publicly confirmed in a global deal as of 2026, but individual case valuations give a realistic picture of what claims may be worth.
Similar mass tort cases involving chemical exposure and serious neurological injury have produced settlements in the range of $100,000 to over $1 million per claimant at the higher end.
Factors that drive settlement value in paraquat cases include:
- Duration of exposure: More years of contact generally means higher value
- Severity of Parkinson’s: Advanced-stage disease commands significantly higher compensation
- Age at diagnosis: Earlier diagnosis in a younger person generally increases damages
- Lost income: Documented lost wages and future earning capacity add to the total
- Medical expenses: The cost of Parkinson’s treatment, caregiving, and medication
No two cases are worth the same amount. A long-tenured pesticide applicator with severe Parkinson’s and significant medical bills will receive more than a bystander with mild early-stage symptoms.
| Settlement Tier | Claimant Profile | Estimated Range |
|---|---|---|
| High value | Long exposure, severe Parkinson’s, significant lost wages | $500,000 to $1M+ |
| Mid value | Moderate exposure, confirmed diagnosis, some lost income | $150,000 to $500,000 |
| Lower value | Limited exposure, early-stage diagnosis, minimal economic loss | $50,000 to $150,000 |
These are estimates based on comparable mass tort outcomes. They are not guarantees.
Key Takeaway: Paraquat case values depend almost entirely on exposure history and disease severity. The more documented your exposure, the stronger your claim.
Paraquat Lawsuit Payout Per Person: Real Numbers
Payout per person in the paraquat litigation is expected to vary widely, but comparable chemical exposure mass torts give useful reference points.
The Roundup (glyphosate) litigation, which also involved a widely used herbicide and serious injury claims, produced individual settlements reported between $5,000 and over $250,000 for non-Hodgkin’s lymphoma cases. Paraquat cases involve a more severe and permanent condition, Parkinson’s disease, which tends to justify higher per-person payouts.
Legal analysts tracking MDL 3004 have informally estimated average paraquat settlement values in the range of $100,000 to $300,000 per claimant for strong cases, with outlier high-value cases reaching seven figures.
Attorney fees in these cases are typically taken on contingency. That means no upfront cost to the plaintiff. Attorney fees usually run 33% to 40% of the final settlement, negotiated before any funds are distributed.
| Cost Factor | Typical Amount |
|---|---|
| Attorney contingency fee | 33% to 40% of settlement |
| Case expenses (medical records, experts) | Deducted from settlement |
| Net payment to client | 60% to 67% of gross settlement |
Understanding these numbers helps set realistic expectations about your take-home amount.
Paraquat MDL Update 2026: What Is Happening in Court
MDL 3004 in the Southern District of Illinois is the centerpiece of all paraquat federal litigation. In 2026, the case is at one of its most consequential stages.
Judge Nancy Rosenstengel has been managing this docket since the MDL was formed. The court has worked through waves of discovery battles, expert witness challenges (Daubert hearings), and pretrial motion practice.
The most significant 2026 development is the bellwether trial program. Bellwether trials function like test runs for a jury. Both sides pick representative cases. Those cases go to trial. The outcomes tell every party in the litigation what a real jury will think about the evidence.
A plaintiff’s verdict in a bellwether trial dramatically increases pressure on defendants to settle the broader litigation. A defense verdict has the opposite effect.
What to watch for in 2026:
- Results of any scheduled bellwether trial verdicts
- Any announcement of a global settlement framework
- New Daubert rulings on expert testimony admissibility
- Court-ordered mediation sessions between parties
The litigation is moving. People with active or pending claims should stay in contact with their legal teams throughout 2026.
How to File a Paraquat Lawsuit in 2026
Filing a paraquat lawsuit in 2026 starts with a free case evaluation from a mass tort attorney. The process is simpler than most people expect.
Here is the basic step-by-step path:
Step 1: Case Evaluation
Contact a law firm that handles paraquat mass tort cases. Most offer free consultations. The attorney will ask about your exposure history, Parkinson’s diagnosis, and where you live.
Step 2: Document Gathering
Your attorney will request medical records showing your Parkinson’s diagnosis. They may also seek employment records, maps of farms you worked on, or statements from coworkers and family members who can attest to your exposure.
Step 3: Filing the Complaint
Once the attorney verifies your eligibility, they file an individual lawsuit. That case gets transferred into MDL 3004 in Illinois and joins the broader litigation pool.
Step 4: Discovery and Case Management
Your case goes through MDL case management. Individual discovery may include depositions, medical examinations, and document reviews.
Step 5: Settlement or Trial
Most mass tort cases settle before trial. If your case is selected as a bellwether trial case, it may go before a jury. Otherwise, your claim likely resolves as part of a global or individual settlement.
- Filing is typically done on contingency: no upfront legal fees
- The entire process from filing to resolution may take 2 to 4 years
- Staying responsive to your attorney’s requests speeds up your case
Paraquat Herbicide and Cancer: Is There a Separate Claim?
The primary injury in the paraquat lawsuit is Parkinson’s disease, but questions about paraquat and cancer come up regularly. Here is what the current science and litigation actually say.
Paraquat has been studied in relation to certain cancers, particularly lung damage and potential carcinogenic effects from acute exposure. However, the mainstream paraquat litigation is centered on Parkinson’s disease, not cancer.
If you were exposed to paraquat and developed a form of cancer rather than Parkinson’s, the situation is more complex. There is no major established MDL for paraquat-cancer claims as of 2026. Individual attorneys may evaluate cancer claims on a case-by-case basis.
The distinction matters because different injuries have different evidentiary standards. Parkinson’s claims have strong, peer-reviewed science behind them. Cancer claims involving paraquat face a harder evidentiary road at this time.
| Injury Type | Current Litigation Status | Science Support |
|---|---|---|
| Parkinson’s disease | Active MDL, thousands of claims | Strong, multi-study consensus |
| Cancer (general) | No major MDL, case-by-case review | Limited, not established consensus |
| Acute paraquat poisoning | Separate legal theory, rare | Well-documented medically |
If you believe paraquat caused a different serious health condition, contact a mass tort attorney for an individual evaluation.
Key Takeaway: The paraquat lawsuit is built on Parkinson’s disease. Cancer claims involving paraquat face a more uncertain legal and scientific path in 2026.
Is the Paraquat Lawsuit Legitimate?
The paraquat lawsuit is completely legitimate. It is not a scam, a frivolous filing, or a manufactured controversy.
MDL 3004 is a real federal docket in the Southern District of Illinois. Thousands of real plaintiffs with real Parkinson’s diagnoses have filed real individual lawsuits. Federal judges have overseen the case for years.
The scientific basis for the claims is grounded in decades of peer-reviewed research funded by the National Institute of Environmental Health Sciences and conducted by independent researchers at major universities.
Paraquat is so well-established as a health risk that it is already banned in over 30 countries, including the European Union, the United Kingdom, Switzerland, and China. The United States is one of the few developed nations where paraquat remains in active agricultural use, which is itself a significant point plaintiffs’ attorneys have raised in court.
The most common way people get misled is by confusing legitimate law firms handling paraquat cases with lead generation operations that collect contact information without providing actual legal services. Work with a law firm that is licensed in your state and has actual mass tort litigation experience.
Frequently Asked Questions
How much money can I get from a paraquat lawsuit?
Most paraquat claims in the strong-to-moderate range are estimated to settle between $100,000 and $500,000 per person.
The exact amount depends on your years of paraquat exposure, the severity of your Parkinson’s disease, your lost income, and your medical expenses.
High-value cases with decades of direct occupational exposure and advanced Parkinson’s may reach or exceed $1 million.
Who qualifies for the paraquat class action lawsuit?
People who qualify are those who had documented or demonstrable paraquat exposure and later received a formal Parkinson’s disease diagnosis.
Exposure categories include licensed pesticide applicators, farm workers, and bystanders who lived near regularly treated fields.
You also need medical records confirming your Parkinson’s diagnosis from a licensed physician or neurologist.
What is the deadline to file a paraquat lawsuit in 2026?
Filing deadlines vary by state but most personal injury statutes of limitations run 2 to 3 years from the date of discovery.
Since major paraquat-Parkinson’s news coverage began in 2021 and 2022, many courts may view 2026 as the final window for new filers.
Do not wait: if you believe you qualify, contact a mass tort attorney immediately to confirm your specific deadline.
How do I prove paraquat exposure for my lawsuit?
Proof of exposure comes from employment records, farm location maps, pesticide purchase receipts, coworker statements, and geographic proximity evidence.
Your attorney handles gathering and presenting this documentation. You do not need a signed paraquat receipt in hand to start the process.
Many claims have been successfully built on employment history, aerial application records, and farm proximity data.
Is the paraquat lawsuit still active in 2026?
Yes, the paraquat lawsuit is fully active in 2026. MDL 3004 is in the bellwether trial phase and new claims are still being accepted.
The litigation has not settled globally, which means your window to file is still open.
Waiting longer reduces that window as statutes of limitations continue to run.
The paraquat lawsuit is real, it is active, and it is moving fast in 2026. If you or someone you love worked with this herbicide and developed Parkinson’s disease, your window to act is right now.
Start by gathering your medical records and any documents connected to your farm work or pesticide exposure. Then get a free case evaluation from a mass tort attorney who handles paraquat claims.
Do not let a deadline close your case before it ever gets started.
